Brunda M J, Minden P, Heusser C H, Ferguson H R
J Immunol. 1978 Mar;120(3):831-6.
Suppression of growth of the line-10 hepatocarcinoma in strain-2 guinea pigs occurred when line-10 cells were injected intradermally together with sera or immunoglobulins derived from normal rabbits. A significant number of animals were resistant to subsequent rechallenge with tumor cells. This immunity was specific, depended on contact of immunoglobulins with tumor cells and on the concentration of immunoglobulins. Repeated injections acted as potent vaccines and resulted in the development of immunity in 84.6% of recipients. Fc receptors were not detected on line-10 cells. Antibodies reacting with line-10 cell unique antigens as well as with antigens common to line-10, line-1 and normal guinea pig spleen cells were found in NRS. Injection of line-10 cells together with rabbit immunoglobulins from which antibodies reacting with antigens derived from line-10 cells had been removed did not result in tumor suppression. The specific antigen(s) recognized by antibodies that suppressed growth of the line-10 tumor in vivo was not determined.
当将10号线肝癌细胞与来自正常兔子的血清或免疫球蛋白一起皮内注射时,2系豚鼠体内的10号线肝癌生长受到抑制。大量动物对随后的肿瘤细胞再攻击具有抗性。这种免疫是特异性的,取决于免疫球蛋白与肿瘤细胞的接触以及免疫球蛋白的浓度。重复注射起到了强效疫苗的作用,使84.6%的接受者产生了免疫力。在10号线细胞上未检测到Fc受体。在正常兔血清中发现了与10号线细胞独特抗原以及与10号线、1号线和正常豚鼠脾细胞共有的抗原发生反应的抗体。将10号线细胞与已去除与10号线细胞衍生抗原发生反应的抗体的兔免疫球蛋白一起注射,不会导致肿瘤抑制。体内抑制10号线肿瘤生长的抗体所识别的特异性抗原尚未确定。